Trials / Recruiting
RecruitingNCT06341413
Sleep and Emotion Processing in Adolescent Post-traumatic Stress Disorder
Sleep and Emotion Processing in Adolescent Post-Traumatic Stress Disorder
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- All
- Age
- 15 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to characterize the role of sleep, emotion processing, and daily affect in post-traumatic stress disorder (PTSD) and whether improving sleep quality using slow wave activity enhancement will impact next-day affect in youth. Participants will attend 4 study visits: * A clinical and trauma assessment visit * A testing day that may include cognitive testing, surveys, and an MRI. * An overnight sleep study following one week of at-home sleep recordings with the device in the sham condition * An overnight sleep study following one week of at-home sleep recordings with the device in the sleep enhancement condition
Detailed description
In this study, researchers aim to characterize sleep and explore its relationship to emotion processing and daily affect in 165 youth spilt into 3 groups. Researchers will use advanced sleep assessment methodologies including: (1) high-density EEG (256 channels) in the laboratory to explore the regional distribution of sleep before and after an emotional learning task and; (2) a sleep-wearable EEG recording headband, SmartSleep, to record sleep longitudinally at home. Using SmartSleep's sleep enhancement algorithms, researchers will determine whether the deepest sleep, slow-wave activity (SWA) of non-rapid eye-movement (NREM) sleep, can be reliably increased in all youth.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SmartSleep device | Device worn during sleep |
Timeline
- Start date
- 2024-07-16
- Primary completion
- 2028-10-01
- Completion
- 2028-12-31
- First posted
- 2024-04-02
- Last updated
- 2026-01-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06341413. Inclusion in this directory is not an endorsement.